Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14076 - 14100 of 14513 in total
Seladelpar (MBX-8025) has been used in trials studying the treatment of Hyperlipidemia.
Investigational
REP8839 is a novel methionyl-tRNA synthetase (MetS) inhibitor being developed by Replidyne (GlaxoSmithKline licensed REP8839 to Replidyne in June of 2003).
Investigational
Experimental
Illicit
Experimental
Experimental
Experimental
GW-3965 is a liver X receptor ligand.
Experimental
Experimental
Experimental
Experimental
Displaying drugs 14076 - 14100 of 14513 in total